Cerity Partners
IMNM icon

Cerity Partners’s Immunome IMNM Stock Holding History

Cerity Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
83,581
+40,789
+95% +$908K ﹤0.01% 1541
2025
Q4 		$919K Sell
42,792
-3,086
-7% -$54.2K ﹤0.01% 1754
2025
Q3 		$537K Sell
45,878
-654
-1% -$6.51K ﹤0.01% 1927
2025
Q2 		$433K Sell
46,532
-5,527
-11% -$45.3K ﹤0.01% 1946
2025
Q1 		$350K Sell
52,059
-619
-1% -$5.94K ﹤0.01% 1943
2024
Q4 		$663K Sell
52,678
-425
-0.8% -$5.14K ﹤0.01% 1610
2024
Q3 		$776K Buy
53,103
+5,043
+10% +$71.7K ﹤0.01% 1532
2024
Q2 		$582K Sell
48,060
-31,163
-39% -$487K ﹤0.01% 1474
2024
Q1 		$1.96M Buy
79,223
+17,877
+29% +$363K 0.01% 981
2023
Q4 		$656K Buy
+61,346
New +$510K ﹤0.01% 1156
2023
Q3 		– Sell
-67,126
Closed -$531K – 1546
2023
Q2 		$531K Buy
67,126
+13,779
+26% +$75.3K ﹤0.01% 1152
2023
Q1 		$266K Hold
53,347
– – ﹤0.01% 1590
2022
Q4 		$118K Sell
53,347
-3,615
-6% -$14.6K ﹤0.01% 1399
2022
Q3 		$253K Hold
56,962
– – ﹤0.01% 965
2022
Q2 		$183K Sell
56,962
-36,584
-39% -$133K ﹤0.01% 1088
2022
Q1 		$531K Sell
93,546
-1,180
-1% -$8.82K 0.01% 579
2021
Q4 		$1.23M Sell
94,726
-7,278
-7% -$130K 0.02% 403
2021
Q3 		$2.48M Sell
102,004
-2,485
-2% -$43.3K 0.05% 237
2021
Q2 		$1.81M Sell
104,489
-5,838
-5% -$129K 0.04% 279
2021
Q1 		$3.74M Sell
110,327
-12,219
-10% -$304K 0.09% 174
2020
Q4 		$1.19M Buy
+122,546
New +$1.43M 0.04% 284

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Cerity Partners's IMNM Position: Q1 2026 in Review

Cerity Partners increased its Immunome (IMNM) stake by 95% in Q1 2026, buying an estimated $908K and bringing the position to 83,581 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Cerity Partners first reported a position in IMNM in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.74M in Q1 2021. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Cerity Partners held 83,581 shares of Immunome worth $1.83M as of Q1 2026.
  • Cerity Partners bought 40,789 Immunome shares in Q1 2026, an estimated $908K.
  • Immunome made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1541 holding.
  • Cerity Partners first reported a position in Immunome in Q4 2020 and has held it in 21 quarters since.
  • Cerity Partners's Immunome position peaked at $3.74M in Q1 2021.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.